Cargando…

Analysing population-based cancer survival – settling the controversies

BACKGROUND: The relative survival field has seen a lot of development in the last decade, resulting in many different and even opposing suggestions on how to approach the analysis. METHODS: We carefully define and explain the differences between the various measures of survival (overall survival, cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pohar Perme, Maja, Estève, Jacques, Rachet, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135814/
https://www.ncbi.nlm.nih.gov/pubmed/27912732
http://dx.doi.org/10.1186/s12885-016-2967-9
_version_ 1782471613946527744
author Pohar Perme, Maja
Estève, Jacques
Rachet, Bernard
author_facet Pohar Perme, Maja
Estève, Jacques
Rachet, Bernard
author_sort Pohar Perme, Maja
collection PubMed
description BACKGROUND: The relative survival field has seen a lot of development in the last decade, resulting in many different and even opposing suggestions on how to approach the analysis. METHODS: We carefully define and explain the differences between the various measures of survival (overall survival, crude mortality, net survival and relative survival ratio) and study their differences using colon and prostate cancer data extracted from the national population-based cancer registry of Slovenia as well as simulated data. RESULTS: The colon and prostate cancer data demonstrate clearly that when analysing population-based data, it is useful to split the overall mortality in crude probabilities of dying from cancer and from other causes. Complemented by net survival, it provides a complete picture of cancer survival in a given population. But when comparisons of different populations as defined for example by place or time are of interest, our simulated data demonstrate that net survival is the only measure to be used. CONCLUSIONS: The choice of the method should be done in two steps: first, one should determine the measure of interest and second, one should choose among the methods that estimate that measure consistently.
format Online
Article
Text
id pubmed-5135814
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51358142016-12-15 Analysing population-based cancer survival – settling the controversies Pohar Perme, Maja Estève, Jacques Rachet, Bernard BMC Cancer Research Article BACKGROUND: The relative survival field has seen a lot of development in the last decade, resulting in many different and even opposing suggestions on how to approach the analysis. METHODS: We carefully define and explain the differences between the various measures of survival (overall survival, crude mortality, net survival and relative survival ratio) and study their differences using colon and prostate cancer data extracted from the national population-based cancer registry of Slovenia as well as simulated data. RESULTS: The colon and prostate cancer data demonstrate clearly that when analysing population-based data, it is useful to split the overall mortality in crude probabilities of dying from cancer and from other causes. Complemented by net survival, it provides a complete picture of cancer survival in a given population. But when comparisons of different populations as defined for example by place or time are of interest, our simulated data demonstrate that net survival is the only measure to be used. CONCLUSIONS: The choice of the method should be done in two steps: first, one should determine the measure of interest and second, one should choose among the methods that estimate that measure consistently. BioMed Central 2016-12-03 /pmc/articles/PMC5135814/ /pubmed/27912732 http://dx.doi.org/10.1186/s12885-016-2967-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pohar Perme, Maja
Estève, Jacques
Rachet, Bernard
Analysing population-based cancer survival – settling the controversies
title Analysing population-based cancer survival – settling the controversies
title_full Analysing population-based cancer survival – settling the controversies
title_fullStr Analysing population-based cancer survival – settling the controversies
title_full_unstemmed Analysing population-based cancer survival – settling the controversies
title_short Analysing population-based cancer survival – settling the controversies
title_sort analysing population-based cancer survival – settling the controversies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135814/
https://www.ncbi.nlm.nih.gov/pubmed/27912732
http://dx.doi.org/10.1186/s12885-016-2967-9
work_keys_str_mv AT poharpermemaja analysingpopulationbasedcancersurvivalsettlingthecontroversies
AT estevejacques analysingpopulationbasedcancersurvivalsettlingthecontroversies
AT rachetbernard analysingpopulationbasedcancersurvivalsettlingthecontroversies